BDBM329007 1137478-41-1::US11787792, Compound Y-150::US9663503, Compound Y-150

SMILES Fc1cccc(c1)-c1cnc(Nc2cnc(cn2)C#N)cc1NC[C@@H]1CNCCO1

InChI Key InChIKey=ICHCXQHWTRNWIJ-UHFFFAOYSA-N

Data  5 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 5 hits for monomerid = 329007   

TargetSerine/threonine-protein kinase Chk1(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM329007(US9663503, Compound Y-150 | 1137478-41-1 | US11787...)
Affinity DataIC50: 17nMAssay Description:CHK1 kinase activity was measured in a microfluidic assay that monitors the separation of a phosphorylated product from its substrate. The assay was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/4/2019
Entry Details
Go to US Patent

TargetSerine/threonine-protein kinase Chk1(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM329007(US9663503, Compound Y-150 | 1137478-41-1 | US11787...)
Affinity DataIC50: 17nMAssay Description:Inhibition of CHK1 (unknown origin) using 5-FAM-KKKVSRSGLYRSPSMPENLNRPR-COOH peptide as substrate incubated for 1 hr in presence of ATP by caliper mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk1(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM329007(US9663503, Compound Y-150 | 1137478-41-1 | US11787...)
Affinity DataIC50: 390nMAssay Description:Inhibition of CHK1 in human HT-29 cells assessed as abrogation of etoposide-induced G2 checkpoint arrest by ELISAMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
LigandPNGBDBM329007(US9663503, Compound Y-150 | 1137478-41-1 | US11787...)
Affinity DataIC50: 8.10E+3nMAssay Description:Displacement of [3H]astemizole from human ERG expressed in HEK293 cells by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
TargetSerine/threonine-protein kinase Chk1(Human)
Cancer Research Technology

US Patent
LigandPNGBDBM329007(US9663503, Compound Y-150 | 1137478-41-1 | US11787...)
Affinity DataIC50: 17nMAssay Description:CHK1 kinase activity was measured in a microfluidic assay that monitors the separation of a phosphorylated product from its substrate. The assay was ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/29/2023
Entry Details
Go to US Patent